Breast cancer (BC) is the main cause of cancer-related mortality among women globally.
Despite substantial advances in the identification and management of primary tumors …

Abstract Design of effective nanomedicines to modulate multiple immune cells to overcome
the immune‐suppressive tumor microenvironment is desirable to improve the overall poor …

Breast cancer (BC) is the most common cause of cancer death in women. According to the
American Cancer Society's yearly cancer statistics, BC constituted almost 15% of all the …

Simple Summary Appropriate testing models are imperative to facilitate the discovery of
effective personalized treatments against different cancers, including advanced cervical …

Tyrosine kinase inhibitors (TKIs) have been extensively used as a treatment for chronic
myeloid leukemia (CML). Dasatinib is a broad-spectrum TKI with off-target effects that give it …

Despite the advent of numerous targeted therapies in clinical practice, anthracyclines,
including doxorubicin (DOX), continue to play a pivotal role in breast cancer (BC) treatment …

Cell surface engineering with exogeneous receptors holds great promise for various
applications. However, current biological methods face problems with safety, antigen …

Breast cancer is a principal cause of cancer-related mortality in female worldwide. While
many approved therapies have shown promising outcomes in treating breast cancer …

Simple Summary Cholangiocarcinoma (CCA) is a malignancy of bile duct epithelial cells,
which has a poor prognosis and high mortality. Consequently, effective therapeutic options …

It is estimated that cancer is the second leading cause of death worldwide. The primary or
secondary cause of cancer-related mortality for women is breast cancer. The main treatment …